Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
161M
-
Number of holders
-
100
-
Total 13F shares, excl. options
-
34.9M
-
Shares change
-
+798K
-
Total reported value, excl. options
-
$318M
-
Value change
-
+$6.98M
-
Put/Call ratio
-
1.05
-
Number of buys
-
58
-
Number of sells
-
-47
-
Price
-
$9.13
Significant Holders of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) as of Q2 2021
122 filings reported holding GRTS - Gritstone bio, Inc. - Common Stock, $0.0001 par value per share as of Q2 2021.
Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) has 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.9M shares
of 161M outstanding shares and own 21.71% of the company stock.
Largest 10 shareholders include Versant Venture Management, LLC (4.45M shares), EcoR1 Capital, LLC (3.42M shares), BlackRock Inc. (2.85M shares), FMR LLC (2.8M shares), Palo Alto Investors LP (2.36M shares), Redmile Group, LLC (2.23M shares), Avidity Partners Management LP (2.12M shares), BVF INC/IL (1.83M shares), VANGUARD GROUP INC (1.42M shares), and D. E. Shaw & Co., Inc. (1.25M shares).
This table shows the top 100 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.